

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.88165106 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.38773631 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.38773631 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.04234175 |
| 5 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.66377971 |
| 6 | negative regulation of cell killing (GO:0031342) | 4.52386808 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.52386808 |
| 8 | detection of other organism (GO:0098543) | 4.44154294 |
| 9 | detection of bacterium (GO:0016045) | 4.43858689 |
| 10 | regulation of gamma-delta T cell activation (GO:0046643) | 4.35673736 |
| 11 | macrophage activation involved in immune response (GO:0002281) | 4.29646641 |
| 12 | positive thymic T cell selection (GO:0045059) | 4.26850296 |
| 13 | positive regulation of B cell differentiation (GO:0045579) | 4.19793311 |
| 14 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.15706126 |
| 15 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.11782973 |
| 16 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.91616753 |
| 17 | regulation of B cell differentiation (GO:0045577) | 3.86783916 |
| 18 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.83273224 |
| 19 | leukocyte aggregation (GO:0070486) | 3.78421717 |
| 20 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.70724247 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 3.70127636 |
| 22 | B cell receptor signaling pathway (GO:0050853) | 3.68646090 |
| 23 | negative thymic T cell selection (GO:0045060) | 3.65734320 |
| 24 | negative T cell selection (GO:0043383) | 3.63274835 |
| 25 | detection of external biotic stimulus (GO:0098581) | 3.60980940 |
| 26 | regulation of mast cell degranulation (GO:0043304) | 3.57851588 |
| 27 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.52350477 |
| 28 | negative regulation of phagocytosis (GO:0050765) | 3.47870423 |
| 29 | negative regulation of T cell mediated immunity (GO:0002710) | 3.43085840 |
| 30 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.41302857 |
| 31 | NIK/NF-kappaB signaling (GO:0038061) | 3.39906408 |
| 32 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.33767881 |
| 33 | response to host immune response (GO:0052572) | 3.33448105 |
| 34 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.33448105 |
| 35 | germinal center formation (GO:0002467) | 3.32775446 |
| 36 | thymic T cell selection (GO:0045061) | 3.31995142 |
| 37 | regulation of leukocyte degranulation (GO:0043300) | 3.30478562 |
| 38 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.28334697 |
| 39 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.26098495 |
| 40 | positive T cell selection (GO:0043368) | 3.21000729 |
| 41 | mannose metabolic process (GO:0006013) | 3.20139075 |
| 42 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.19484812 |
| 43 | regulation of tolerance induction (GO:0002643) | 3.17825916 |
| 44 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.15988269 |
| 45 | response to host (GO:0075136) | 3.15988269 |
| 46 | response to host defenses (GO:0052200) | 3.15988269 |
| 47 | negative regulation of granulocyte differentiation (GO:0030853) | 3.14714509 |
| 48 | detection of biotic stimulus (GO:0009595) | 3.14693353 |
| 49 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.11785792 |
| 50 | T cell selection (GO:0045058) | 3.08853438 |
| 51 | tolerance induction (GO:0002507) | 3.06808944 |
| 52 | positive regulation by symbiont of host defense response (GO:0052509) | 3.04297102 |
| 53 | modulation by symbiont of host defense response (GO:0052031) | 3.04297102 |
| 54 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.04297102 |
| 55 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.04297102 |
| 56 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.04297102 |
| 57 | modulation by symbiont of host immune response (GO:0052553) | 3.04297102 |
| 58 | detection of molecule of bacterial origin (GO:0032490) | 3.03788169 |
| 59 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.03224811 |
| 60 | B cell mediated immunity (GO:0019724) | 2.98279359 |
| 61 | response to muramyl dipeptide (GO:0032495) | 2.98164703 |
| 62 | positive regulation of antigen processing and presentation (GO:0002579) | 2.97760224 |
| 63 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.96518906 |
| 64 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.95342338 |
| 65 | macrophage activation (GO:0042116) | 2.93842582 |
| 66 | microglial cell activation (GO:0001774) | 2.93697095 |
| 67 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.93269924 |
| 68 | activated T cell proliferation (GO:0050798) | 2.92044664 |
| 69 | T cell migration (GO:0072678) | 2.91645382 |
| 70 | negative regulation of interleukin-6 production (GO:0032715) | 2.90466202 |
| 71 | negative regulation of innate immune response (GO:0045824) | 2.89391491 |
| 72 | natural killer cell differentiation (GO:0001779) | 2.88849748 |
| 73 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.88287099 |
| 74 | response to interleukin-15 (GO:0070672) | 2.87666407 |
| 75 | leukocyte degranulation (GO:0043299) | 2.85772753 |
| 76 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.85709253 |
| 77 | positive regulation of mast cell activation (GO:0033005) | 2.83951815 |
| 78 | neutrophil activation involved in immune response (GO:0002283) | 2.83816768 |
| 79 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.81980494 |
| 80 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.81762104 |
| 81 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.81474105 |
| 82 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.81474105 |
| 83 | regulation of granulocyte differentiation (GO:0030852) | 2.81353366 |
| 84 | regulation of mast cell activation (GO:0033003) | 2.80793221 |
| 85 | positive regulation of granulocyte differentiation (GO:0030854) | 2.80455863 |
| 86 | regulation of regulated secretory pathway (GO:1903305) | 2.79894748 |
| 87 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.79421455 |
| 88 | T cell homeostasis (GO:0043029) | 2.79210979 |
| 89 | leukocyte cell-cell adhesion (GO:0007159) | 2.78092082 |
| 90 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.76093059 |
| 91 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.75475915 |
| 92 | neutrophil activation (GO:0042119) | 2.75155439 |
| 93 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.72782835 |
| 94 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.72135201 |
| 95 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.71484000 |
| 96 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.71484000 |
| 97 | cellular extravasation (GO:0045123) | 2.71149200 |
| 98 | interferon-gamma production (GO:0032609) | 2.68709893 |
| 99 | negative regulation of type 2 immune response (GO:0002829) | 2.68611765 |
| 100 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.66793239 |
| 101 | mature B cell differentiation (GO:0002335) | 2.66437962 |
| 102 | negative regulation of interleukin-12 production (GO:0032695) | 2.66124974 |
| 103 | lymphocyte homeostasis (GO:0002260) | 2.63786070 |
| 104 | positive regulation of isotype switching (GO:0045830) | 2.63331714 |
| 105 | regulation of necroptotic process (GO:0060544) | 2.62525830 |
| 106 | respiratory burst (GO:0045730) | 2.61239499 |
| 107 | cellular response to zinc ion (GO:0071294) | 2.60458455 |
| 108 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.58778061 |
| 109 | T cell receptor signaling pathway (GO:0050852) | 2.55547354 |
| 110 | response to peptidoglycan (GO:0032494) | 2.54837571 |
| 111 | regulation of erythrocyte differentiation (GO:0045646) | 2.54401297 |
| 112 | regulation of antigen processing and presentation (GO:0002577) | 2.54324124 |
| 113 | pinocytosis (GO:0006907) | 2.54126515 |
| 114 | myeloid dendritic cell activation (GO:0001773) | 2.53009276 |
| 115 | positive regulation of histone deacetylation (GO:0031065) | 2.52479025 |
| 116 | mast cell activation (GO:0045576) | 2.52430950 |
| 117 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.51178338 |
| 118 | regulation of response to interferon-gamma (GO:0060330) | 2.51122092 |
| 119 | actin nucleation (GO:0045010) | 2.50885299 |
| 120 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.49986226 |
| 121 | mature B cell differentiation involved in immune response (GO:0002313) | 2.49839161 |
| 122 | natural killer cell activation (GO:0030101) | 2.49340125 |
| 123 | ribosomal small subunit assembly (GO:0000028) | 2.48393221 |
| 124 | response to type I interferon (GO:0034340) | 2.47067697 |
| 125 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.46041125 |
| 126 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.45736315 |
| 127 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.45621547 |
| 128 | positive regulation of lamellipodium assembly (GO:0010592) | 2.45533542 |
| 129 | megakaryocyte development (GO:0035855) | 2.45526596 |
| 130 | lymph node development (GO:0048535) | 2.44986008 |
| 131 | granulocyte activation (GO:0036230) | 2.44257180 |
| 132 | regulation of T cell tolerance induction (GO:0002664) | 2.43602921 |
| 133 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.43217516 |
| 134 | defense response to protozoan (GO:0042832) | 2.41938390 |
| 135 | positive regulation of protein deacetylation (GO:0090312) | 2.41337474 |
| 136 | T cell costimulation (GO:0031295) | 2.41218193 |
| 137 | cellular response to type I interferon (GO:0071357) | 2.40155467 |
| 138 | type I interferon signaling pathway (GO:0060337) | 2.40155467 |
| 139 | leukocyte homeostasis (GO:0001776) | 2.39914303 |
| 140 | response to protozoan (GO:0001562) | 2.38149467 |
| 141 | cellular response to interleukin-15 (GO:0071350) | 2.36386510 |
| 142 | lymphocyte costimulation (GO:0031294) | 2.35755622 |
| 143 | myeloid cell activation involved in immune response (GO:0002275) | 2.35529236 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.39388203 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.48806775 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.38768145 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.01593214 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.99987392 |
| 6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.98847791 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.97265219 |
| 8 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.92219695 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.90601421 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.72133700 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.71473005 |
| 12 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.60616560 |
| 13 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.45826635 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.39678369 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.36739126 |
| 16 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.31976419 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.30137211 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.24076743 |
| 19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.21288030 |
| 20 | MYB_26560356_Chip-Seq_TH2_Human | 2.18124644 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.17173412 |
| 22 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.15801874 |
| 23 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.14010184 |
| 24 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.11497981 |
| 25 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.10221980 |
| 26 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.09984752 |
| 27 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.08275761 |
| 28 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.03085703 |
| 29 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.00399875 |
| 30 | MYB_26560356_Chip-Seq_TH1_Human | 1.99340693 |
| 31 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.97595529 |
| 32 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.96219632 |
| 33 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.95076251 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.94904776 |
| 35 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.92865608 |
| 36 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.92828380 |
| 37 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.90213326 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.89794294 |
| 39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.86986281 |
| 40 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86723876 |
| 41 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.86152567 |
| 42 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84701950 |
| 43 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.83435161 |
| 44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78649992 |
| 45 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.73044135 |
| 46 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.71169033 |
| 47 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.70401818 |
| 48 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70026867 |
| 49 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.64849781 |
| 50 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.64230735 |
| 51 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.61685986 |
| 52 | MAF_26560356_Chip-Seq_TH2_Human | 1.55338715 |
| 53 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52720685 |
| 54 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.50325987 |
| 55 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.50025724 |
| 56 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.46303197 |
| 57 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.46019224 |
| 58 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.46012570 |
| 59 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.45569088 |
| 60 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.44319583 |
| 61 | P68_20966046_ChIP-Seq_HELA_Human | 1.41227494 |
| 62 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.40761731 |
| 63 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.40118795 |
| 64 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.39806818 |
| 65 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39611948 |
| 66 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.38879531 |
| 67 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.37170434 |
| 68 | KDM2B_26808549_Chip-Seq_K562_Human | 1.34455529 |
| 69 | GATA1_19941826_ChIP-Seq_K562_Human | 1.34332583 |
| 70 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34331648 |
| 71 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.30041015 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.29902692 |
| 73 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.29877795 |
| 74 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.29767048 |
| 75 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26814830 |
| 76 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.22146865 |
| 77 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.20296089 |
| 78 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.17715313 |
| 79 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.16283769 |
| 80 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16262772 |
| 81 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15692136 |
| 82 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15082466 |
| 83 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14329930 |
| 84 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.14251758 |
| 85 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.12979918 |
| 86 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11858719 |
| 87 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.10431863 |
| 88 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.09825296 |
| 89 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09363522 |
| 90 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.08405043 |
| 91 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.06694300 |
| 92 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.05634811 |
| 93 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05400018 |
| 94 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.04378223 |
| 95 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04245224 |
| 96 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04178885 |
| 97 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.04076325 |
| 98 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03931027 |
| 99 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.03816590 |
| 100 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.02620330 |
| 101 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02618426 |
| 102 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.02001752 |
| 103 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.01266319 |
| 104 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01195924 |
| 105 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.01142056 |
| 106 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.98877501 |
| 107 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.96597364 |
| 108 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.96123753 |
| 109 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96057785 |
| 110 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.95083043 |
| 111 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94955599 |
| 112 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.94816158 |
| 113 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.94339886 |
| 114 | * XRN2_22483619_ChIP-Seq_HELA_Human | 0.94025710 |
| 115 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.93860994 |
| 116 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92562209 |
| 117 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.92156494 |
| 118 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91779567 |
| 119 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89306658 |
| 120 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.88556129 |
| 121 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85943392 |
| 122 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.85605303 |
| 123 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.85301369 |
| 124 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.83548933 |
| 125 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.82942098 |
| 126 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.80133877 |
| 127 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.80032763 |
| 128 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79842307 |
| 129 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79178888 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.61552649 |
| 2 | MP0000685_abnormal_immune_system | 3.24397954 |
| 3 | MP0005671_abnormal_response_to | 2.88990738 |
| 4 | MP0003763_abnormal_thymus_physiology | 2.88581719 |
| 5 | MP0001800_abnormal_humoral_immune | 2.81872876 |
| 6 | MP0002396_abnormal_hematopoietic_system | 2.76422524 |
| 7 | MP0001790_abnormal_immune_system | 2.67532318 |
| 8 | MP0005387_immune_system_phenotype | 2.67532318 |
| 9 | MP0009278_abnormal_bone_marrow | 2.62216792 |
| 10 | MP0003436_decreased_susceptibility_to | 2.60836481 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.50532437 |
| 12 | MP0002398_abnormal_bone_marrow | 2.42249203 |
| 13 | MP0002420_abnormal_adaptive_immunity | 2.41216308 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.39769919 |
| 15 | MP0001819_abnormal_immune_cell | 2.39125156 |
| 16 | MP0002723_abnormal_immune_serum | 2.38994346 |
| 17 | MP0005025_abnormal_response_to | 2.28417647 |
| 18 | MP0009785_altered_susceptibility_to | 2.26910431 |
| 19 | MP0003303_peritoneal_inflammation | 2.24468985 |
| 20 | MP0002405_respiratory_system_inflammati | 2.20180554 |
| 21 | MP0002419_abnormal_innate_immunity | 2.19522572 |
| 22 | MP0004808_abnormal_hematopoietic_stem | 2.18254516 |
| 23 | MP0001545_abnormal_hematopoietic_system | 2.17746209 |
| 24 | MP0005397_hematopoietic_system_phenotyp | 2.17746209 |
| 25 | MP0000716_abnormal_immune_system | 2.14622841 |
| 26 | MP0002166_altered_tumor_susceptibility | 2.14564713 |
| 27 | MP0000689_abnormal_spleen_morphology | 2.12468767 |
| 28 | MP0005464_abnormal_platelet_physiology | 2.05784164 |
| 29 | MP0008260_abnormal_autophagy | 2.04146432 |
| 30 | MP0002722_abnormal_immune_system | 2.04060152 |
| 31 | MP0001873_stomach_inflammation | 2.01753634 |
| 32 | MP0009333_abnormal_splenocyte_physiolog | 1.99191557 |
| 33 | MP0005451_abnormal_body_composition | 1.94364926 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.90413808 |
| 35 | MP0002429_abnormal_blood_cell | 1.87373007 |
| 36 | MP0000703_abnormal_thymus_morphology | 1.86530529 |
| 37 | MP0005058_abnormal_lysosome_morphology | 1.82143322 |
| 38 | MP0003693_abnormal_embryo_hatching | 1.80163639 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.79487756 |
| 40 | MP0006082_CNS_inflammation | 1.79403354 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.78420215 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.68413784 |
| 43 | MP0004381_abnormal_hair_follicle | 1.67048243 |
| 44 | MP0003172_abnormal_lysosome_physiology | 1.66531755 |
| 45 | MP0002006_tumorigenesis | 1.62283476 |
| 46 | MP0004947_skin_inflammation | 1.61507987 |
| 47 | MP0000490_abnormal_crypts_of | 1.59302868 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.55223932 |
| 49 | MP0001853_heart_inflammation | 1.51773945 |
| 50 | MP0003077_abnormal_cell_cycle | 1.46849318 |
| 51 | MP0005174_abnormal_tail_pigmentation | 1.46339447 |
| 52 | MP0004510_myositis | 1.43843120 |
| 53 | MP0003866_abnormal_defecation | 1.39467912 |
| 54 | MP0003183_abnormal_peptide_metabolism | 1.39355939 |
| 55 | MP0003191_abnormal_cellular_cholesterol | 1.38387360 |
| 56 | MP0008057_abnormal_DNA_replication | 1.38311907 |
| 57 | MP0000858_altered_metastatic_potential | 1.37369179 |
| 58 | MP0010094_abnormal_chromosome_stability | 1.28727627 |
| 59 | MP0005075_abnormal_melanosome_morpholog | 1.27465586 |
| 60 | MP0005310_abnormal_salivary_gland | 1.27101329 |
| 61 | MP0009840_abnormal_foam_cell | 1.26492892 |
| 62 | MP0002933_joint_inflammation | 1.25397099 |
| 63 | MP0010352_gastrointestinal_tract_polyps | 1.25051093 |
| 64 | MP0002019_abnormal_tumor_incidence | 1.22319529 |
| 65 | MP0001533_abnormal_skeleton_physiology | 1.21773467 |
| 66 | MP0003724_increased_susceptibility_to | 1.20180103 |
| 67 | MP0010307_abnormal_tumor_latency | 1.19640963 |
| 68 | MP0003111_abnormal_nucleus_morphology | 1.18508998 |
| 69 | MP0008007_abnormal_cellular_replicative | 1.15609531 |
| 70 | MP0000569_abnormal_digit_pigmentation | 1.14613340 |
| 71 | MP0008469_abnormal_protein_level | 1.12411476 |
| 72 | MP0003448_altered_tumor_morphology | 1.10323667 |
| 73 | MP0005076_abnormal_cell_differentiation | 1.01527771 |
| 74 | MP0004883_abnormal_blood_vessel | 1.00372756 |
| 75 | MP0005023_abnormal_wound_healing | 0.99461577 |
| 76 | MP0003566_abnormal_cell_adhesion | 0.97785866 |
| 77 | MP0005390_skeleton_phenotype | 0.94425260 |
| 78 | MP0003075_altered_response_to | 0.94046716 |
| 79 | MP0000313_abnormal_cell_death | 0.93621393 |
| 80 | MP0000015_abnormal_ear_pigmentation | 0.92800315 |
| 81 | MP0005166_decreased_susceptibility_to | 0.88392843 |
| 82 | MP0003690_abnormal_glial_cell | 0.87806131 |
| 83 | MP0004957_abnormal_blastocyst_morpholog | 0.87466348 |
| 84 | MP0003705_abnormal_hypodermis_morpholog | 0.87234938 |
| 85 | MP0008058_abnormal_DNA_repair | 0.85797290 |
| 86 | MP0005670_abnormal_white_adipose | 0.85670281 |
| 87 | MP0001348_abnormal_lacrimal_gland | 0.84851601 |
| 88 | MP0001851_eye_inflammation | 0.84570353 |
| 89 | MP0003091_abnormal_cell_migration | 0.81585836 |
| 90 | MP0002138_abnormal_hepatobiliary_system | 0.81443920 |
| 91 | MP0003045_fibrosis | 0.81192344 |
| 92 | MP0000350_abnormal_cell_proliferation | 0.80848764 |
| 93 | MP0008961_abnormal_basal_metabolism | 0.79227970 |
| 94 | MP0002277_abnormal_respiratory_mucosa | 0.79147959 |
| 95 | MP0005377_hearing/vestibular/ear_phenot | 0.78410183 |
| 96 | MP0003878_abnormal_ear_physiology | 0.78410183 |
| 97 | MP0002009_preneoplasia | 0.77379111 |
| 98 | MP0000343_altered_response_to | 0.76149445 |
| 99 | MP0005164_abnormal_response_to | 0.76147702 |
| 100 | MP0000604_amyloidosis | 0.72818742 |
| 101 | MP0000371_diluted_coat_color | 0.71082505 |
| 102 | MP0008004_abnormal_stomach_pH | 0.70181094 |
| 103 | MP0003656_abnormal_erythrocyte_physiolo | 0.70064782 |
| 104 | MP0002928_abnormal_bile_duct | 0.69848729 |
| 105 | MP0001986_abnormal_taste_sensitivity | 0.69498532 |
| 106 | MP0003795_abnormal_bone_structure | 0.68624570 |
| 107 | MP0004858_abnormal_nervous_system | 0.68389754 |
| 108 | MP0001849_ear_inflammation | 0.68276627 |
| 109 | MP0008874_decreased_physiological_sensi | 0.66989585 |
| 110 | MP0004130_abnormal_muscle_cell | 0.65809905 |
| 111 | MP0003828_pulmonary_edema | 0.65363982 |
| 112 | MP0004185_abnormal_adipocyte_glucose | 0.64629509 |
| 113 | MP0002095_abnormal_skin_pigmentation | 0.64484064 |
| 114 | MP0002998_abnormal_bone_remodeling | 0.62771310 |
| 115 | MP0003279_aneurysm | 0.60787185 |
| 116 | MP0005621_abnormal_cell_physiology | 0.60322015 |
| 117 | MP0000477_abnormal_intestine_morphology | 0.60301946 |
| 118 | MP0002132_abnormal_respiratory_system | 0.59912316 |
| 119 | MP0009763_increased_sensitivity_to | 0.59793888 |
| 120 | MP0001730_embryonic_growth_arrest | 0.58744965 |
| 121 | MP0009764_decreased_sensitivity_to | 0.57857298 |
| 122 | MP0000249_abnormal_blood_vessel | 0.57834164 |
| 123 | MP0001663_abnormal_digestive_system | 0.57187475 |
| 124 | MP0005083_abnormal_biliary_tract | 0.56387378 |
| 125 | MP0005666_abnormal_adipose_tissue | 0.55906200 |
| 126 | MP0004264_abnormal_extraembryonic_tissu | 0.55832559 |
| 127 | MP0003453_abnormal_keratinocyte_physiol | 0.55403963 |
| 128 | MP0005381_digestive/alimentary_phenotyp | 0.54318586 |
| 129 | MP0000598_abnormal_liver_morphology | 0.53809531 |
| 130 | MP0003943_abnormal_hepatobiliary_system | 0.53295549 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.61133524 |
| 2 | Recurrent viral infections (HP:0004429) | 4.23276377 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.19149606 |
| 4 | Nasal polyposis (HP:0100582) | 4.17132161 |
| 5 | Recurrent fungal infections (HP:0002841) | 4.08295428 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 4.06311508 |
| 7 | IgM deficiency (HP:0002850) | 4.03441332 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.00027728 |
| 9 | Recurrent bronchitis (HP:0002837) | 3.89522002 |
| 10 | Chronic otitis media (HP:0000389) | 3.83858191 |
| 11 | Abnormality of the nasal mucosa (HP:0000433) | 3.82739457 |
| 12 | Panhypogammaglobulinemia (HP:0003139) | 3.72709858 |
| 13 | Gastrointestinal infarctions (HP:0005244) | 3.68120461 |
| 14 | Myositis (HP:0100614) | 3.58013001 |
| 15 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.54753364 |
| 16 | Cellulitis (HP:0100658) | 3.52098281 |
| 17 | T lymphocytopenia (HP:0005403) | 3.49066601 |
| 18 | Abnormality of the fingertips (HP:0001211) | 3.42102383 |
| 19 | Abnormality of T cell number (HP:0011839) | 3.33249577 |
| 20 | Gastrointestinal inflammation (HP:0004386) | 3.29831146 |
| 21 | Inflammation of the large intestine (HP:0002037) | 3.27809668 |
| 22 | Thyroiditis (HP:0100646) | 3.27310914 |
| 23 | Thrombocytosis (HP:0001894) | 3.22447633 |
| 24 | Abnormality of T cells (HP:0002843) | 3.19145703 |
| 25 | Encephalitis (HP:0002383) | 3.12669408 |
| 26 | Colitis (HP:0002583) | 3.11712176 |
| 27 | Combined immunodeficiency (HP:0005387) | 3.09347018 |
| 28 | Agammaglobulinemia (HP:0004432) | 3.08615155 |
| 29 | Severe combined immunodeficiency (HP:0004430) | 3.07804774 |
| 30 | Meningitis (HP:0001287) | 3.07276459 |
| 31 | Recurrent skin infections (HP:0001581) | 2.97404386 |
| 32 | Autoimmune thrombocytopenia (HP:0001973) | 2.97170578 |
| 33 | Pustule (HP:0200039) | 2.88400569 |
| 34 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.87767022 |
| 35 | Recurrent cutaneous fungal infections (HP:0011370) | 2.87767022 |
| 36 | Abnormality of B cell number (HP:0010975) | 2.86224053 |
| 37 | B lymphocytopenia (HP:0010976) | 2.86224053 |
| 38 | Leukocytosis (HP:0001974) | 2.83478410 |
| 39 | Mediastinal lymphadenopathy (HP:0100721) | 2.81989220 |
| 40 | Abnormality of T cell physiology (HP:0011840) | 2.78408030 |
| 41 | Hypochromic anemia (HP:0001931) | 2.77867253 |
| 42 | Eosinophilia (HP:0001880) | 2.77445094 |
| 43 | Petechiae (HP:0000967) | 2.76270046 |
| 44 | Abnormality of macrophages (HP:0004311) | 2.71736553 |
| 45 | Prolonged bleeding time (HP:0003010) | 2.71721971 |
| 46 | Urticaria (HP:0001025) | 2.70599165 |
| 47 | Spontaneous hematomas (HP:0007420) | 2.69135734 |
| 48 | Keratoconjunctivitis sicca (HP:0001097) | 2.66477235 |
| 49 | Lymphopenia (HP:0001888) | 2.65761423 |
| 50 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.63148604 |
| 51 | Abnormality of eosinophils (HP:0001879) | 2.61594356 |
| 52 | Vasculitis (HP:0002633) | 2.57084743 |
| 53 | Granulocytopenia (HP:0001913) | 2.56288855 |
| 54 | Episodic fever (HP:0001954) | 2.55456347 |
| 55 | Periodontitis (HP:0000704) | 2.55406222 |
| 56 | Vacuolated lymphocytes (HP:0001922) | 2.50653269 |
| 57 | Hypochromic microcytic anemia (HP:0004840) | 2.49058339 |
| 58 | Bronchitis (HP:0012387) | 2.48910111 |
| 59 | Interstitial pulmonary disease (HP:0006530) | 2.48422835 |
| 60 | Abnormal platelet function (HP:0011869) | 2.47494999 |
| 61 | Impaired platelet aggregation (HP:0003540) | 2.47494999 |
| 62 | Obstructive lung disease (HP:0006536) | 2.47318111 |
| 63 | Chronic obstructive pulmonary disease (HP:0006510) | 2.47318111 |
| 64 | Dysostosis multiplex (HP:0000943) | 2.46671490 |
| 65 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.41968044 |
| 66 | Keratoconjunctivitis (HP:0001096) | 2.40440061 |
| 67 | Gingivitis (HP:0000230) | 2.35633823 |
| 68 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.34818564 |
| 69 | Osteomyelitis (HP:0002754) | 2.33438582 |
| 70 | Increased IgE level (HP:0003212) | 2.31157600 |
| 71 | Papilloma (HP:0012740) | 2.30132015 |
| 72 | Verrucae (HP:0200043) | 2.30132015 |
| 73 | Epistaxis (HP:0000421) | 2.29494608 |
| 74 | Lymphoma (HP:0002665) | 2.29141148 |
| 75 | Obstructive sleep apnea (HP:0002870) | 2.25851413 |
| 76 | Orchitis (HP:0100796) | 2.24725831 |
| 77 | Slow saccadic eye movements (HP:0000514) | 2.21624480 |
| 78 | Arterial thrombosis (HP:0004420) | 2.21500591 |
| 79 | Gingival bleeding (HP:0000225) | 2.20376670 |
| 80 | Emphysema (HP:0002097) | 2.19006594 |
| 81 | Loss of speech (HP:0002371) | 2.18981771 |
| 82 | Pulmonary embolism (HP:0002204) | 2.16594152 |
| 83 | IgG deficiency (HP:0004315) | 2.16576287 |
| 84 | Recurrent sinusitis (HP:0011108) | 2.15942578 |
| 85 | Increased cerebral lipofuscin (HP:0011813) | 2.13672299 |
| 86 | Papilledema (HP:0001085) | 2.13659339 |
| 87 | Amyloidosis (HP:0011034) | 2.13299111 |
| 88 | Chest pain (HP:0100749) | 2.13259754 |
| 89 | Stomatitis (HP:0010280) | 2.10868473 |
| 90 | Gastrointestinal stroma tumor (HP:0100723) | 2.09800521 |
| 91 | Increased serum ferritin (HP:0003281) | 2.09443888 |
| 92 | Purpura (HP:0000979) | 2.09287256 |
| 93 | Increased IgM level (HP:0003496) | 2.09057745 |
| 94 | Albinism (HP:0001022) | 2.08454075 |
| 95 | Thoracic kyphosis (HP:0002942) | 2.04186385 |
| 96 | Peritonitis (HP:0002586) | 2.03107381 |
| 97 | Pulmonary infiltrates (HP:0002113) | 2.02478747 |
| 98 | Abnormality of glycolipid metabolism (HP:0010969) | 2.01902243 |
| 99 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.01902243 |
| 100 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.01902243 |
| 101 | Chronic diarrhea (HP:0002028) | 2.01760187 |
| 102 | Hemorrhage of the eye (HP:0011885) | 2.01244174 |
| 103 | Hypoplasia of the thymus (HP:0000778) | 1.99759612 |
| 104 | Spondylolisthesis (HP:0003302) | 1.98108656 |
| 105 | Abnormality of the thoracic spine (HP:0100711) | 1.97679293 |
| 106 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.97678379 |
| 107 | Recurrent pneumonia (HP:0006532) | 1.97562865 |
| 108 | Restrictive lung disease (HP:0002091) | 1.97050386 |
| 109 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.97035436 |
| 110 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.96776786 |
| 111 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.96776786 |
| 112 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.96776786 |
| 113 | IgA deficiency (HP:0002720) | 1.95951956 |
| 114 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.95799956 |
| 115 | Mucopolysacchariduria (HP:0008155) | 1.95799956 |
| 116 | Chronic sinusitis (HP:0011109) | 1.95612604 |
| 117 | Anorexia (HP:0002039) | 1.95423688 |
| 118 | Poikiloderma (HP:0001029) | 1.95344157 |
| 119 | Microcytic anemia (HP:0001935) | 1.95196637 |
| 120 | Viral hepatitis (HP:0006562) | 1.94719369 |
| 121 | Malnutrition (HP:0004395) | 1.93509557 |
| 122 | Skin ulcer (HP:0200042) | 1.93101884 |
| 123 | Acne (HP:0001061) | 1.92037429 |
| 124 | Hypergammaglobulinemia (HP:0010702) | 1.90598064 |
| 125 | Premature loss of primary teeth (HP:0006323) | 1.90311772 |
| 126 | High pitched voice (HP:0001620) | 1.89424592 |
| 127 | Sepsis (HP:0100806) | 1.89194220 |
| 128 | Broad face (HP:0000283) | 1.88860226 |
| 129 | Hepatosplenomegaly (HP:0001433) | 1.88594924 |
| 130 | Optic neuritis (HP:0100653) | 1.88258514 |
| 131 | Retrobulbar optic neuritis (HP:0100654) | 1.88258514 |
| 132 | Hemoptysis (HP:0002105) | 1.87396150 |
| 133 | Abnormality of the pleura (HP:0002103) | 1.86229111 |
| 134 | Polygenic inheritance (HP:0010982) | 1.85665057 |
| 135 | Recurrent lower respiratory tract infections (HP:0002783) | 1.85534462 |
| 136 | Abnormality of the peritoneum (HP:0002585) | 1.84601649 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.72482639 |
| 2 | PRPF4B | 3.14057287 |
| 3 | MAP3K10 | 2.75026340 |
| 4 | STK10 | 2.65308531 |
| 5 | EEF2K | 2.63802259 |
| 6 | ERN1 | 2.60957251 |
| 7 | TYK2 | 2.56563248 |
| 8 | ZAP70 | 2.34191454 |
| 9 | BLK | 2.34026270 |
| 10 | CSF1R | 2.23763260 |
| 11 | TGFBR2 | 2.18941704 |
| 12 | KIT | 2.15485165 |
| 13 | CDK12 | 2.14248364 |
| 14 | BTK | 2.06834521 |
| 15 | GRK6 | 1.96965560 |
| 16 | JAK3 | 1.91658394 |
| 17 | SIK1 | 1.87780066 |
| 18 | TXK | 1.81718945 |
| 19 | TBK1 | 1.76254683 |
| 20 | IRAK4 | 1.62532494 |
| 21 | ITK | 1.61067228 |
| 22 | NEK2 | 1.60817518 |
| 23 | SMG1 | 1.56936114 |
| 24 | SYK | 1.53523628 |
| 25 | IKBKE | 1.53387286 |
| 26 | MAP3K3 | 1.47094979 |
| 27 | CSK | 1.44663191 |
| 28 | TRIB3 | 1.38314372 |
| 29 | HCK | 1.36426465 |
| 30 | JAK1 | 1.33061469 |
| 31 | MAP2K3 | 1.32614653 |
| 32 | RPS6KA4 | 1.31383425 |
| 33 | TAOK3 | 1.30535571 |
| 34 | TEC | 1.30404767 |
| 35 | FGFR4 | 1.29302088 |
| 36 | IKBKB | 1.27685682 |
| 37 | CAMK1D | 1.27393450 |
| 38 | PKN2 | 1.26706441 |
| 39 | EPHB1 | 1.25806309 |
| 40 | LCK | 1.25196922 |
| 41 | FLT3 | 1.24858248 |
| 42 | LRRK2 | 1.22882716 |
| 43 | MAP3K1 | 1.19678041 |
| 44 | MAP3K14 | 1.14612238 |
| 45 | TESK2 | 1.12596258 |
| 46 | CDC42BPA | 1.10877402 |
| 47 | PIM1 | 1.10313660 |
| 48 | PTK6 | 1.03426422 |
| 49 | CDK4 | 1.02464678 |
| 50 | CLK1 | 1.01636173 |
| 51 | PAK4 | 0.99365132 |
| 52 | SIK2 | 0.98781650 |
| 53 | KDR | 0.98214085 |
| 54 | RPS6KB2 | 0.97963613 |
| 55 | KSR2 | 0.97156784 |
| 56 | FGR | 0.96703020 |
| 57 | CHUK | 0.95801754 |
| 58 | LYN | 0.93851317 |
| 59 | FES | 0.93793455 |
| 60 | TAOK2 | 0.88647061 |
| 61 | PDK1 | 0.88284190 |
| 62 | CAMK1G | 0.88123510 |
| 63 | STK4 | 0.87983330 |
| 64 | MAP3K13 | 0.84330701 |
| 65 | PDPK1 | 0.83798351 |
| 66 | RIPK4 | 0.83126290 |
| 67 | MAPKAPK3 | 0.82667767 |
| 68 | CAMKK1 | 0.82494771 |
| 69 | MAPK12 | 0.80515634 |
| 70 | FGFR3 | 0.80121526 |
| 71 | NLK | 0.78183384 |
| 72 | MARK3 | 0.77290980 |
| 73 | NME2 | 0.76301336 |
| 74 | HIPK2 | 0.74166937 |
| 75 | IRAK3 | 0.73737178 |
| 76 | JAK2 | 0.71287795 |
| 77 | MAP3K8 | 0.70024185 |
| 78 | MAPK7 | 0.69411569 |
| 79 | BRD4 | 0.68480889 |
| 80 | DYRK3 | 0.67219628 |
| 81 | MAP3K6 | 0.67026571 |
| 82 | TAOK1 | 0.66152101 |
| 83 | RIPK1 | 0.65579103 |
| 84 | CDK6 | 0.65293507 |
| 85 | ATR | 0.65177062 |
| 86 | MATK | 0.65138701 |
| 87 | TGFBR1 | 0.64959078 |
| 88 | STK38 | 0.64354841 |
| 89 | IRAK2 | 0.64301639 |
| 90 | ICK | 0.64013287 |
| 91 | ACVR1B | 0.63246430 |
| 92 | TTN | 0.63221241 |
| 93 | IRAK1 | 0.63188951 |
| 94 | PASK | 0.60974112 |
| 95 | TESK1 | 0.60916622 |
| 96 | MAP2K2 | 0.60189388 |
| 97 | CDC7 | 0.58558257 |
| 98 | MAP3K11 | 0.57882307 |
| 99 | CDK7 | 0.57412008 |
| 100 | PIM2 | 0.56655286 |
| 101 | RPS6KA2 | 0.55947685 |
| 102 | MARK2 | 0.55666807 |
| 103 | TRPM7 | 0.54648911 |
| 104 | RET | 0.54637657 |
| 105 | MAP3K7 | 0.54451326 |
| 106 | MAPKAPK2 | 0.52815109 |
| 107 | FYN | 0.51058894 |
| 108 | MAPK11 | 0.50578834 |
| 109 | YES1 | 0.49868195 |
| 110 | TNK2 | 0.49134891 |
| 111 | SIK3 | 0.48103513 |
| 112 | MAP2K6 | 0.47832141 |
| 113 | CDK9 | 0.47776566 |
| 114 | MAPK15 | 0.45341811 |
| 115 | PRKCH | 0.44652194 |
| 116 | DYRK1B | 0.42923043 |
| 117 | STK11 | 0.42416099 |
| 118 | BMX | 0.42136049 |
| 119 | PRKCQ | 0.41873405 |
| 120 | MTOR | 0.41138744 |
| 121 | SGK3 | 0.40619219 |
| 122 | RPS6KA6 | 0.38554709 |
| 123 | MELK | 0.38175385 |
| 124 | PRKD2 | 0.38105570 |
| 125 | SCYL2 | 0.36937712 |
| 126 | MAPK4 | 0.36454346 |
| 127 | WEE1 | 0.35774660 |
| 128 | BUB1 | 0.31437233 |
| 129 | RPS6KC1 | 0.30604802 |
| 130 | RPS6KL1 | 0.30604802 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.55769390 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.58589211 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.25959843 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.21645231 |
| 5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.20203370 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.09970063 |
| 7 | DNA replication_Homo sapiens_hsa03030 | 2.05450443 |
| 8 | Other glycan degradation_Homo sapiens_hsa00511 | 2.03657124 |
| 9 | Measles_Homo sapiens_hsa05162 | 1.93869037 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.91322269 |
| 11 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.85984693 |
| 12 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.83308653 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.82977289 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.82604443 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.82312093 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.77080921 |
| 17 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.72207104 |
| 18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.71723852 |
| 19 | Base excision repair_Homo sapiens_hsa03410 | 1.64905011 |
| 20 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.54808090 |
| 21 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.53352580 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.53132682 |
| 23 | Mismatch repair_Homo sapiens_hsa03430 | 1.49756948 |
| 24 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.47165436 |
| 25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.47105541 |
| 26 | Shigellosis_Homo sapiens_hsa05131 | 1.43345990 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.41688617 |
| 28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.39497673 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.38624312 |
| 30 | Hepatitis B_Homo sapiens_hsa05161 | 1.34361082 |
| 31 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.31930287 |
| 32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.31111933 |
| 33 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.31070022 |
| 34 | Apoptosis_Homo sapiens_hsa04210 | 1.30236937 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.27888858 |
| 36 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.26188885 |
| 37 | Legionellosis_Homo sapiens_hsa05134 | 1.25818757 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.24103674 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.21968215 |
| 40 | Pertussis_Homo sapiens_hsa05133 | 1.19070107 |
| 41 | Tuberculosis_Homo sapiens_hsa05152 | 1.13965565 |
| 42 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.13730078 |
| 43 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.13199661 |
| 44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.12083226 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.12047005 |
| 46 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.11955739 |
| 47 | Homologous recombination_Homo sapiens_hsa03440 | 1.08995119 |
| 48 | Cell cycle_Homo sapiens_hsa04110 | 1.08467018 |
| 49 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.08059302 |
| 50 | Spliceosome_Homo sapiens_hsa03040 | 1.07482512 |
| 51 | Lysosome_Homo sapiens_hsa04142 | 1.07167971 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.05339106 |
| 53 | Ribosome_Homo sapiens_hsa03010 | 1.04307111 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.03711644 |
| 55 | Malaria_Homo sapiens_hsa05144 | 1.02240496 |
| 56 | Viral myocarditis_Homo sapiens_hsa05416 | 1.00169009 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.99991352 |
| 58 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.98448061 |
| 59 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.98216933 |
| 60 | HTLV-I infection_Homo sapiens_hsa05166 | 0.98001078 |
| 61 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.96879527 |
| 62 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.94784665 |
| 63 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.94203741 |
| 64 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.93699544 |
| 65 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.92352996 |
| 66 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.91237716 |
| 67 | Phagosome_Homo sapiens_hsa04145 | 0.90778739 |
| 68 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.87678875 |
| 69 | Salmonella infection_Homo sapiens_hsa05132 | 0.85935344 |
| 70 | Endometrial cancer_Homo sapiens_hsa05213 | 0.85555200 |
| 71 | Colorectal cancer_Homo sapiens_hsa05210 | 0.82414687 |
| 72 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81782519 |
| 73 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.80120725 |
| 74 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.79403474 |
| 75 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78314634 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.78245811 |
| 77 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.77971896 |
| 78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.75753088 |
| 79 | Allograft rejection_Homo sapiens_hsa05330 | 0.75720153 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73920565 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.73372602 |
| 82 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.71922518 |
| 83 | RNA transport_Homo sapiens_hsa03013 | 0.70060326 |
| 84 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.68532278 |
| 85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68367922 |
| 86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68077141 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.67500022 |
| 88 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.67290862 |
| 89 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.66513734 |
| 90 | Hepatitis C_Homo sapiens_hsa05160 | 0.66107375 |
| 91 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.65883655 |
| 92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63167828 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62876872 |
| 94 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.62634518 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.62333697 |
| 96 | Amoebiasis_Homo sapiens_hsa05146 | 0.59435252 |
| 97 | Asthma_Homo sapiens_hsa05310 | 0.57335159 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.57180141 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57152913 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56627229 |
| 101 | RNA degradation_Homo sapiens_hsa03018 | 0.56109796 |
| 102 | Lysine degradation_Homo sapiens_hsa00310 | 0.55740806 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55580104 |
| 104 | Prostate cancer_Homo sapiens_hsa05215 | 0.54869085 |
| 105 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.53754921 |
| 106 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53649432 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.51714406 |
| 108 | Endocytosis_Homo sapiens_hsa04144 | 0.51573952 |
| 109 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51477512 |
| 110 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51425903 |
| 111 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.48312142 |
| 112 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.47168685 |
| 113 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47000231 |
| 114 | Glioma_Homo sapiens_hsa05214 | 0.45985980 |
| 115 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.45931775 |
| 116 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.45566485 |
| 117 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.45231819 |
| 118 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.44700041 |
| 119 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44695687 |
| 120 | Insulin resistance_Homo sapiens_hsa04931 | 0.44158179 |
| 121 | Sulfur relay system_Homo sapiens_hsa04122 | 0.43896364 |
| 122 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.42886301 |
| 123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42728206 |
| 124 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.42446514 |
| 125 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.42067345 |
| 126 | Pathways in cancer_Homo sapiens_hsa05200 | 0.41577970 |
| 127 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40670176 |
| 128 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.39946512 |
| 129 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.38814963 |
| 130 | Basal transcription factors_Homo sapiens_hsa03022 | 0.38480385 |
| 131 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37333548 |

